Table 1.
Responses to treatment at the end of therapy n (%)
T-a1 (n = 18) |
IFN-α (n = 33) |
HC (n = 30) |
|
(after 6 mo of follow-up) | |||
ALT normalization | 7 (38.9) | 16 (48.5) | 5 (16.7) |
HBV DNA-negative | 10 (55.6)b | 22 (66.7)b | 2 (6.7) |
ALT normal/HBV DNA and HBeAg-negative | 6 (33.3) | 15 (45.5)b | 1 (3.3) |
P < 0.01, vs HC.